Research Results

Beta Version

Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.

Search by keyword

Try these: air pollutionalcoholbisphenolshormonespersonal care productspesticidesplastic

Filter by Risk Factors
Filter by Protective Factors
Filter by Exposure Sources
Filter by Chemical Classes

Sort By

  • Relevance
  • Title (A to Z)
  • Title (Z to A)
  • Publication Year (Ascending)
  • Publication Year (Descending)
  • Authors (A to Z)
  • Authors (Z to A)

Multiple xenoestrogen air pollutants and breast cancer risk: Statistical approaches to investigate combined exposures effect.

Amadou et al,

2024

Environ Pollut

A French study of over 10,000 women found that combined exposure to a mixture of four hormone-disrupting air pollutants (benzo[a]pyrene, cadmium, dioxin, and PCB153) was associated with an approximately 10-11% increased risk of breast cancer. Using advanced statistical methods that account for simultaneous exposure to multiple pollutants rather than examining each separately, researchers found that benzo[a]pyrene, cadmium, and PCB153 showed the strongest individual contributions to increased breast cancer risk within the mixture. This research provides important evidence that the cumulative effect of multiple air pollutants acting together on hormone pathways may be a significant risk factor for breast cancer development.

Ambient polycyclic aromatic hydrocarbon exposure and breast cancer risk in a population-based Canadian case-control study.

Hinton et al,

2024

Cancer Causes Cont

This large Canadian population-based study examined whether long-term residential exposure to polycyclic aromatic hydrocarbons (PAHs)—widespread environmental pollutants from sources like vehicle exhaust and industrial emissions—increases breast cancer risk. Using 20 years of residential history data, researchers found that exposure to fluoranthene (a common PAH) was associated with significantly increased risk of premenopausal breast cancer, with women in moderately high exposure areas showing 59-148% higher risk compared to those in low-exposure areas. The associations with postmenopausal breast cancer were inconsistent, with only one analysis showing a modest increased risk. These findings support the hypothesis that ambient PAH exposure may increase the risk of breast cancer in premenopausal women, though the relationship appears complex and requires further investigation.

Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.

Modica et al,

2023

J Endocrinol Invest

A comprehensive literature review examining environmental endocrine-disrupting chemicals (EDCs) and hormone-related cancers concludes that several EDCs can be definitively classified as carcinogenic, including dioxin and cadmium for breast and thyroid cancer, arsenic and dioxin for prostate cancer, and organochlorines for testicular cancer. The review highlights that fetuses and newborns are most vulnerable to endocrine disruption, with adverse effects potentially manifesting at different ages throughout life, making it difficult to assess the full health impact of EDC exposure. The authors emphasize that EDCs represent a major environmental health issue requiring effective prevention policies, increased public awareness, and protective measures—particularly for pregnant women—along with standardized testing criteria to evaluate the carcinogenic potential of new chemicals before they enter widespread use.

Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Chang et al,

2023

Int J Cancer

This study of over 1,200 postmenopausal women found that higher blood levels of PFOS (a common “forever chemical” found in items like stain-resistant fabrics and food packaging) were associated with 59-134% increased risk of hormone receptor-positive breast cancers, while PFOA (another widespread PFAS chemical) showed modest associations with hormone receptor-negative tumors. PFAS are called “forever chemicals” because they persist indefinitely in the environment and human body, and these findings suggest they may contribute to breast cancer through hormone disruption. These results add to growing concerns about PFAS exposure from contaminated water, food packaging, and consumer products, though the different associations for PFOS and PFOA by tumor subtype require further investigation to fully understand how these chemicals affect breast cancer development.

Endocrine-disrupting chemicals: A Systematic Review of Epidemiological Studies

Wan et al,

2022

Crit Rev Food Sci Nutr

A systematic review of 131 epidemiological studies examining endocrine-disrupting chemicals (EDCs) and breast cancer risk found evidence that exposure to various EDCs—including pesticides (DDT/DDE, atrazine, dioxin), synthetic chemicals (BPA, phthalates, PFAS, PCBs, PBDEs), and other compounds found in everyday products—may elevate breast cancer risk, particularly when exposure occurs during early life. The review identified food as a major route of EDC exposure and emphasized that because most EDCs persist in the environment and accumulate in the body over time, long-term multi-generational health impacts need to be assessed. The authors call for improved exposure assessments of EDCs in food and food packaging, along with careful evaluation of their links to breast cancer development to inform policy-making and regulations aimed at protecting public health.

Elevated levels of perfluoroalkyl substances in breast cancer patients within the Greater Manila Area.

Velarde et al,

2022

Chemosphere

Researchers measured 41 endocrine-disrupting chemicals (EDCs) in women living in the Greater Manila Area, Philippines, comparing those with and without breast cancer. They found that certain perfluoroalkyl substances (PFAS) were significantly associated with breast cancer, with some chemicals showing dramatically increased risk: PFDoA was associated with a 1,263% increased risk, PFDA with an 826% increased risk, and PFHxA with a 166% increased risk. Long-chain PFAS levels were higher in women from heavily industrialized areas compared to the National Capital Region. This study provides the first baseline data on EDC exposure levels in Filipino women, filling a critical gap in knowledge about chemical exposures in Southeast Asian populations and suggesting that industrial pollution may be contributing to elevated PFAS levels and breast cancer risk.

Positive association between dietary exposure to polybrominated diphenyl ethers and breast cancer risk in the French E3N cohort: The role of vegetable oil consumption.

Frenoy et al,

2022

Environ Int

A large French study of nearly 68,000 women followed for over 21 years found that dietary exposure to PBDEs (flame retardant chemicals) was associated with increased breast cancer risk, but importantly, this association was modified by vegetable oil consumption. Women who consumed higher amounts of vegetable oil (≥4.6 g/day) and had the highest PBDE intake showed a 23% increased breast cancer risk, while those with low vegetable oil consumption showed no increased risk regardless of PBDE exposure. These findings suggest that the interaction between diet and chemical contaminants is important to consider when developing public health recommendations, as certain dietary patterns may amplify or mitigate the health risks associated with environmental chemical exposures.

A cross-sectional study of the association between perfluorinated chemical exposure and cancers related to deregulation of estrogen receptors.

Omoike et al,

2021

Environ Res

This large U.S. study using NHANES data found that multiple PFAS chemicals were associated with increased odds of both breast and ovarian cancer, with dose-response relationships showing dramatically higher risks at the highest exposure levels—women in the highest quartile of exposure had 130% increased odds for breast cancer (up to 607% for PFHxS) and 77-125% increased odds for ovarian cancer compared to those in the lowest quartile. Different PFAS chemicals showed stronger correlations with different cancers: PFOA was most strongly correlated with breast cancer while PFHxS was most strongly correlated with ovarian cancer, suggesting these endocrine-disrupting chemicals may affect different hormone-sensitive tissues through distinct mechanisms. No associations were found with prostate or uterine cancers. These findings are particularly concerning because PFAS are ubiquitous environmental contaminants found in everyday products and the water supply, and the strong dose-response relationships suggest that reducing PFAS exposure could potentially lower the risk of these estrogen-related cancers in women.

A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women.

Tsai et al,

2020

Environ Int

This Taiwanese study of 239 women found that higher plasma levels of PFOS (a “forever chemical”) were associated with 134% increased breast cancer risk in women aged 50 and younger, with each natural log unit increase in exposure more than doubling the odds of developing the disease. Both PFOS and PFHxS (another PFAS chemical) showed positive associations specifically with estrogen receptor-positive breast tumors in younger women, suggesting these endocrine-disrupting chemicals may particularly affect hormone-sensitive breast cancers during reproductive years. These findings are concerning because PFAS are ubiquitous environmental contaminants found in water, food packaging, and consumer products, and the study adds to growing evidence that these persistent chemicals may contribute to rising breast cancer rates among younger women. The results highlight the potential health consequences of widespread PFAS contamination, particularly for women of reproductive age who may face elevated risk of hormone-driven breast cancers.

Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the French E3N cohort.

Mancini et al,

2020

Int J Cancer

his French study of 388 women found that higher blood levels of PFOS (a “forever chemical”) were associated with 122-133% increased breast cancer risk for estrogen receptor-positive tumors and 147-176% increased risk for progesterone receptor-positive tumors, with a clear dose-response relationship showing increasing risk at higher exposure levels. Interestingly, the study found different patterns for hormone receptor-negative tumors, where only low-to-moderate levels of PFOS and PFOA were associated with dramatically increased risk (up to 1,440% for estrogen receptor-negative tumors at moderate PFOS levels). These findings suggest that PFAS chemicals—which are widespread in human blood worldwide due to contamination from products like stain-resistant fabrics, non-stick cookware, and food packaging—may contribute to breast cancer through different mechanisms depending on tumor type, highlighting the complexity of how these persistent environmental chemicals affect breast cancer risk.

Prepubertal and Pubertal Endocrine-Disrupting Chemical Exposure and Breast Density among Chilean Adolescents.

Binder et al,

2018

Cancer Epidemiol Biomarkers Prev

This study examined how exposure to endocrine-disrupting chemicals (EDCs) during puberty affects breast tissue development in 200 Chilean girls by measuring urinary concentrations of phenols and phthalates at two stages of breast development and assessing breast density. The researchers found that certain phthalate metabolites were associated with increased breast density measures – specifically, higher levels of monocarboxyisooctyl phthalate were linked to 7% higher percent dense breast tissue, and monoethyl phthalate was associated with increased fibroglandular volume. Bisphenol A showed a U-shaped relationship with fibroglandular volume, where girls with middle-level exposures had at least 10% lower fibroglandular volume compared to those with low or high exposures. The findings suggest that developing breast tissue is vulnerable to certain EDCs during childhood and adolescence, which may have implications for future breast cancer risk since breast density is a known risk factor.

Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.

Eberle et al,

Cancer Epidemiol

A study of 46,709 women in the Sister Study found that use of permanent hair dye and chemical straighteners was associated with increased breast cancer risk, with particularly strong associations among Black women. Permanent hair dye use was linked to a 45% increased risk in Black women, while chemical straightener use showed an 18% increased risk overall, with higher risks associated with more frequent use. Women who applied semipermanent dyes to others showed a 28% increased risk. These findings suggest that endocrine-disrupting chemicals and carcinogens in hair products, which are often present at higher concentrations in products marketed to Black women, may contribute to breast cancer development.

Effects of endocrine disrupting chemicals, blood metabolome, and epigenetics on breast cancer risk: A multi-dimensional mendelian randomization study.

Song et al,

2025

Ecotoxicol Env Saf

A Mendelian randomization study using genetic data from European populations found that specific endocrine-disrupting chemicals (EDCs) were causally associated with different breast cancer subtypes: n-butyl paraben (n-BuP) increased Luminal A risk, mono-methyl phthalate decreased Luminal B risk, and mono-iso-butyl phthalate (MiBP) increased triple-negative breast cancer risk. Mediation analysis revealed that blood metabolites—including caffeic acid sulfate and caffeine metabolism ratios—partially explained the n-BuP effect on Luminal A, while methylsuccinate mediated the MiBP effect on triple-negative cancer, and epigenetic analysis identified specific DNA methylation sites associated with EDC exposure and breast cancer risk. These findings provide the first genetic evidence suggesting causal relationships between specific EDC exposures and breast cancer subtypes through distinct metabolic and epigenetic pathways, identifying potential biomarkers for early detection and highlighting the heterogeneous effects of different EDCs on breast cancer biology—underscoring the need for chemical-specific and subtype-specific prevention strategies rather than treating all EDCs or breast cancers as uniform entities.

Associations between phenol and paraben exposure and the risk of developing breast cancer in adult women: a cross-sectional study.

Xiong et al,

2025

Sci Rep

A large U.S. study of 4,455 people found that exposure to triclosan (TRS)—an antibacterial chemical commonly found in soaps, toothpaste, and personal care products—was associated with more than double the risk of breast cancer at moderate exposure levels, with the relationship following an inverted U-shape pattern. The association was strongest among overweight individuals, people under 60 years old, and white participants, while other tested chemicals (including bisphenol A, benzophenone-3, and parabens) showed no significant link to breast cancer risk. These findings suggest that triclosan exposure may be an important modifiable risk factor for breast cancer, particularly for certain population groups, though more research is needed to understand the underlying mechanisms and confirm causality.

Environmental endocrine disrupting chemical-DEHP exposure-provoked biotoxicity about microbiota-gut-mammary axis in lactating mice via multi-omics technologies.

Xu et al,

2024

Environ Int

A study in mice found that exposure to DEHP—a common chemical used to make plastics flexible—disrupts the gut-mammary connection, causing changes in gut bacteria, intestinal inflammation, and direct damage to mammary (breast) tissue that could impair milk production. DEHP altered gut microbiome composition (increasing some bacteria while decreasing others), changed blood metabolite levels, and its breakdown product (MEHP) triggered cell death in mammary tissue through multiple pathways. These findings raise concerns about DEHP exposure from plastics affecting both human breast health and dairy production in livestock, while identifying potential therapeutic targets to counteract the chemical’s harmful effects on the gut-breast axis.

Endocrine disruptors: Unravelling the link between chemical exposure and Women’s reproductive health.

Hassan et al,

2024

Environ Res

Endocrine Disrupting Chemicals (EDCs)—including bisphenol A, phthalates, parabens, pesticides, and heavy metals commonly found in pharmaceuticals, cosmetics, and packaging—are widespread environmental pollutants that interfere with the body’s hormone system. Research shows EDCs have harmful effects on women’s reproductive health, contributing to conditions such as endometriosis, polycystic ovary syndrome, uterine fibroids, premature ovarian failure, menstrual irregularities, and infertility. This review emphasizes the need for healthcare professionals to consider environmental exposures when evaluating patients, highlights potential mechanisms by which EDCs affect female reproduction, and discusses how nutritional interventions and stricter environmental regulations could help reduce EDC-related health risks. Understanding the link between EDCs and women’s health is crucial for developing protective strategies, informing treatment approaches, and shaping public policies to safeguard reproductive and overall well-being. The study seeks to advise that couples attempting to conceive should avoid endocrine disrupting chemicals (EDCs) such as BPA, pesticides, and phthalates. Following this advice is found to be crucial during the prenatal and periconceptional periods, where fetal development and growth are critical in this window.

Personal Care Products, Socioeconomic Status, and Endocrine-Disrupting Chemical Mixtures in Black Women.

Schildroth et al,

2024

Environ Sci Technol

A study of 751 reproductive-aged Black women found that the relationship between personal care product (PCP) use and exposure to endocrine-disrupting chemicals (EDCs) varied significantly by socioeconomic status (SES), with different patterns of chemical exposure from the same products depending on women’s education, income, and employment. For example, vaginal powder use was associated with higher phenol exposure (a class of EDCs) among lower SES women but showed no such association in higher SES women, suggesting that product formulations, brands, or usage patterns may differ across SES groups. These findings highlight that Black women face inequitable EDC exposures that are influenced by both race and socioeconomic factors, underscoring the need for targeted public health interventions that address these intersecting disparities in chemical exposures from everyday products

Hair Dye and Relaxer Use among Cisgender Women in Embu and Nakuru Counties, Kenya: Associations with Perceived Risk of Breast Cancer and Other Health Effects.

Llanos et al,

2024

Int J Env Res Pub Health

This study surveyed 746 Kenyan women about their hair product use and found that nearly 60% had used chemical relaxers and one-third had used hair dyes, despite many expressing concerns about health risks including breast cancer. Older women and those working in sales and service industries were more likely to use these products, which may contain endocrine-disrupting chemicals linked to breast cancer. Surprisingly, women’s awareness of potential health risks did not consistently lead to reduced use of these products, suggesting that concern alone may not be enough to change behavior. These findings are particularly important for Kenya, where breast cancer rates are rising, and highlight the need for better education about chemical exposures in hair products and strategies to reduce potentially harmful exposures.

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data.

Kay et al,

2024

Environ Health Perspect

Researchers analyzed 279 chemicals known to cause mammary tumors in rodents and identified 642 additional chemicals that activate estrogen or progesterone signaling, finding that tumor-causing chemicals were significantly more likely to stimulate hormone production, activate estrogen receptors, or damage DNA—characteristics that likely increase breast cancer risk in humans. The study found that more mammary carcinogens worked by increasing hormone production than by directly activating estrogen receptors, with chemicals showing stronger hormone-disrupting effects being most likely to cause tumors, demonstrating a clear dose-response relationship. These findings suggest that hundreds of chemicals currently in use may pose unrecognized breast cancer risks and should not be assumed safe without specific testing for breast effects, with the strongest evidence chemicals prioritized for exposure reduction and improved testing methods needed to identify additional hazardous substances. The research provides a framework for identifying and regulating chemicals that may contribute to breast cancer through hormone disruption and genetic damage—mechanisms supported by both animal and human studies.

Ultra-processed and fast food consumption, exposure to phthalates during pregnancy, and socioeconomic disparities in phthalate exposures.

Baker et al,

2024

Environ Int

A study of 1,031 pregnant women from the socioeconomically diverse CANDLE cohort in the urban South found that ultra-processed foods constituted 38.6% of participants’ diets on average, with each 10% higher dietary proportion of ultra-processed foods associated with 13.1% higher urinary concentrations of DEHP phthalate metabolites, while specific foods like hamburgers, French fries, soda, and cake showed 6-10.5% higher DEHP per standard deviation increase in consumption. Causal mediation analyses revealed that lower income and education levels were associated with 1.9% and 1.4% higher DEHP exposure respectively, mediated through increased ultra-processed food consumption, indicating that ultra-processed foods contribute to socioeconomic disparities in phthalate exposure during pregnancy. The findings demonstrate that consuming ultra-processed foods increases exposure to endocrine-disrupting phthalates from food contact materials, and because socioeconomic barriers can prevent dietary modifications, policies to reduce phthalates in food packaging and processing are needed rather than relying solely on individual dietary recommendations to reduce prenatal phthalate exposures.

Endocrine-Disrupting Chemicals and Persistent Organic Pollutants in Infant Formulas and Baby Food: Legislation and Risk Assessments.

Hatzidaki et al,

2023

Foods

A review of regulations for endocrine-disrupting chemicals and persistent organic pollutants in infant formula found that while breast milk remains the healthiest option, infant formula must be strictly monitored to ensure it is pollutant-free, particularly given the vulnerability of newborns to chemical exposures. Current regulations and upper limits for contaminants in infant formula vary worldwide, though standardized policies exist to protect infants, and continuous monitoring is required to maintain safety standards. The authors emphasize that risk assessment studies are limited but urgently needed to better understand exposure variations and evaluate the health risks infants face from dietary exposure to pollutants during this critical developmental period.

Bisphenols and alternative developers in thermal paper receipts from the U.S. market assessed by Fourier transform infrared spectroscopy.

Miller et al,

2023

Environ Pollut

A 2022 study tested 571 cash register receipts from U.S. retailers to assess endocrine-disrupting chemicals in thermal paper and compared findings to a 2017 study. Bisphenol S (BPS) was found in 85% of receipts, Pergafast 201 in 12%, and bisphenol A (BPA) in only 1%, indicating a shift away from BPA. National retailers were more likely than local ones to use non-bisphenol alternatives. These findings highlight potential health risks from handling receipts, as BPS and other chemicals can still pose significant exposure concerns.

In vitro transcriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals.

Matteo et al,

2023

Toxicol Sci

A high-throughput transcriptomic study using MCF-7 breast cancer cells exposed to BPA and 15 alternative chemicals (0.0005-100 µM for 48 hours) found that 8 alternative chemicals activated estrogen receptor alpha (ERα), with bisphenol AF identified as the most potent, followed by BPA and bisphenol C, and benchmark concentration analysis revealing that BPA and transcriptionally active alternatives enriched similar gene sets associated with increased cell division and cancer-related processes at comparable concentrations. Global transcriptomic and ERα-specific points of departure produced highly consistent potency rankings, and pathway analysis showed that active alternatives induced hazards similar to BPA through shared molecular mechanisms. These findings reveal that many BPA replacement chemicals used since initial 2010 Canadian regulatory action are not safer alternatives and may pose similar or greater hazards at comparable exposure levels despite being data-poor compounds with limited toxicological assessment, supporting the use of transcriptomic profiling for read-across risk assessment of structurally related chemicals and raising concerns about regrettable substitution in which one harmful chemical is simply replaced with equally harmful alternatives.

Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.

Wan et al,

2022

Crit Rev Food Sci Nutr

This systematic review of 131 epidemiological studies evaluated the association between various endocrine-disrupting chemicals, including phthalates and hormonal exposures like contraceptive pills, and the risk of breast cancer. It found that several EDCs, particularly phthalates and oral contraceptive use, were consistently associated with increased breast cancer risk across multiple studies.

Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.

Santaliz Casiano et al,

2022

Endocrinology

A review examining PFAS (found in nonstick cookware, food packaging, and stain-resistant fabrics) and parabens (used in personal care products) found that exposure to these endocrine-disrupting chemicals is linked to breast cancer development, with marginalized and socially disadvantaged communities facing disproportionately higher exposures due to structural racism and inequitable environmental conditions. These disparities in chemical exposure may contribute to poorer breast cancer outcomes in these populations, yet breast cancer research continues to underrepresent these communities, limiting our ability to address treatment disparities and improve survival rates. The authors emphasize the urgent need to both reduce EDC exposures in vulnerable communities and increase research inclusion of diverse populations to understand how environmental injustices intersect with breast cancer risk and develop interventions that address these health inequities.

Influence of Temperature on the Quantity of Bisphenol A in Bottled Drinking Water.

Ginter-Kramarczyk et al,

2022

Int J Environ Res Public Health

A recent study highlights the risk of Bisphenol A (BPA) exposure from bottled water, emphasizing how temperature can influence BPA leaching into the water. While BPA isn’t used in PET bottle manufacturing, contamination can occur due to recycled materials. Findings indicate that BPA levels in bottled water increase with temperature, even when not at the highest temperatures. BPA, a known endocrine-disrupting chemical (EDC), is linked to reproductive health issues, developmental disorders, and even cancer.

Endocrine disrupting chemicals and breast cancer cells.

Darbre et al,

2021

Adv Pharmacol

A comprehensive review examining endocrine-disrupting chemicals (EDCs) in breast tissue concludes that hundreds of these environmental chemicals are entering human breast tissue and contributing to the global rise in breast cancer incidence through multiple biological mechanisms. Laboratory studies demonstrate that EDCs can activate all the established “hallmarks of cancer” in human breast cancer cells—even at concentrations measured in actual human breast tissue—with effects amplified when chemicals are present as mixtures rather than individually. The authors argue that EDCs must now be formally recognized as a breast cancer risk factor to enable prevention strategies that include reducing environmental chemical exposures, particularly given that the varied mixtures of EDCs found in individual breast tissues act through overlapping mechanisms to promote cancer development.

Update on the Health Effects of Bisphenol A: Overwhelming Evidence of Harm.

Vom Saal et al,

2021

Endocrinology

A comprehensive review of bisphenol A (BPA) research spanning over 20 years—from the landmark 1997 study showing reproductive effects in male mouse offspring at 2 µg/kg/day through the CLARITY-BPA study designed to bridge regulatory and scientific disagreements—found that thousands of animal studies and over 100 epidemiological studies report adverse effects at low doses, with CLARITY-BPA showing effects at 2.5 µg/kg/day, leading independent experts to recommend dropping the lowest observed adverse effect level 20,000-fold from 50,000 to 2.5 µg/kg/day. Despite this overwhelming evidence, the FDA continues to assert BPA is safe by rejecting low-dose data as “not biologically plausible” based on four incorrect assumptions criticized by the Endocrine Society as violating basic principles of endocrinology: that dose responses must be monotonic, thresholds exist below which there are no effects, both sexes must respond similarly, and only traditional toxicological guideline studies are valid. The review highlights a fundamental divide between regulatory approaches and endocrine science, demonstrating that traditional toxicology methods are insufficient for evaluating endocrine-disrupting chemicals like BPA, which can cause non-monotonic dose responses, sex-specific effects, and low-dose effects that challenge conventional assumptions about chemical safety, yet regulatory agencies continue to ignore modern endocrinology principles in favor of outdated toxicological paradigms.

Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.

Zhao et al,

2019

PLOS One

Bisphenol AF (BPAF)—a chemical increasingly used to replace BPA in consumer products—shows even stronger estrogen-like effects than BPA and promotes the growth of estrogen receptor-positive (ER+) breast cancer cells through multiple hormone signaling pathways. Laboratory studies revealed that BPAF stimulates cancer cell proliferation by activating estrogen receptors and upregulating AREG, a growth-promoting gene, with blocking either estrogen receptors or AREG preventing BPAF’s cancer-promoting effects. These findings challenge the assumption that BPA alternatives are safer, demonstrating that BPAF may pose equal or greater breast cancer risks than the chemical it’s replacing, and highlight the urgent need for human studies to assess BPAF’s impact on breast cancer risk before its continued widespread use in products marketed as “BPA-free.”

Designing Endocrine Disruption Out of the Next Generation of Chemicals.

Schug et al,

2013

Green Chemistry

Scientists have developed TiPED (Tiered Protocol for Endocrine Disruption), a voluntary five-tier testing system designed to help chemists identify hormone-disrupting properties in new chemicals during the design phase—before they enter consumer products—ranging from computer-based predictions to cell and animal studies. The protocol was created by experts in green chemistry and environmental health to broadly test whether new chemicals can mimic or block hormones or interfere with hormone signaling, which is critical for preventing endocrine disruption that can contribute to diseases like breast cancer. Testing of six known endocrine disruptors with different mechanisms of action successfully identified all of them, demonstrating the protocol’s effectiveness, though the system will continue evolving as scientific understanding advances. This tool represents an important shift toward preventing chemical hazards at the design stage rather than discovering them years later after widespread human exposure, which could significantly reduce public health risks including breast cancer.

Endocrine disruptors and asthma-associated chemicals in consumer products.

Dodson et al,

2012

Environ Health Perspect

This study analyzed 213 everyday products, including cosmetics, cleaners, and personal care items, for endocrine-disrupting chemicals (EDCs) and asthma-related compounds. Testing revealed 55 chemicals, with fragranced products and sunscreens containing the highest levels. Vinyl products were also found to contain significant amounts of bis(2-ethylhexyl) phthalate (DEHP), a known EDC. Many harmful chemicals were not listed on product labels, limiting consumer ability to avoid them. These results highlight the presence of potentially harmful chemicals in commonly used products, raising concerns about their widespread use in household and personal care items.

Heavy metals and phthalate contamination in prenatal vitamins and folic acid supplements

Gardener et al.

2025

Environ Res

A study analyzing 156 commercially available prenatal vitamins, 19 folate/folic acid supplements, and 9 prescription prenatals found widespread contamination with heavy metals and phthalates: 83% of commercial prenatals contained detectable lead (15% exceeding California’s 0.5 μg/daily threshold), 73% contained cadmium, 25% contained DEHP, and 13% contained DBP, with higher contamination associated with calcium and iron content and caplet/capsule/tablet formulations. Prescription prenatals also showed contamination, with 7 of 9 containing detectable lead or cadmium and 33% exceeding the lead threshold, while folate/folic acid supplements showed lower contamination levels. These findings reveal that pregnant women—a population particularly vulnerable to environmental chemical exposures—are being exposed to lead, cadmium, and endocrine-disrupting phthalates through the very supplements intended to support healthy pregnancy. Since prenatal supplementation remains critical for fetal development, pregnant women should prioritize products with third-party verification seals (such as USP, NSF International, or ConsumerLab) which confirm label accuracy, purity, and manufacturing standards, and clear, enforceable regulations requiring frequent testing and strict contamination limits are urgently needed.

A review on advances in removal of endocrine disrupting compounds from aquatic matrices: Future perspectives on utilization of agri-waste based adsorbents.

Surana et al,

2022

Sci Total Environ

A comprehensive review of endocrine-disrupting compounds (EDCs) in water systems found that these emerging contaminants pose significant health risks to humans and aquatic life, yet conventional water treatment processes fail to remove them effectively and no regulatory discharge limits currently exist. The review examined various treatment approaches (physical, chemical, biological, and hybrid methods) and identified agricultural waste-based adsorbents as a promising, low-cost, and sustainable solution for efficiently removing EDCs from water. Research findings indicate that these abundantly available agri-waste materials can effectively capture EDCs, offering an economical alternative to conventional treatment methods, though the review also highlights ongoing challenges and the need for further development of these technologies to address the growing threat of endocrine-disrupting pollution in water supplies.

A comprehensive assessment of endocrine-disrupting chemicals in an Indian food basket: Levels, dietary intakes, and comparison with European data.

Sharma et al,

2021

Environ Pollut

A study comparing endocrine-disrupting chemical (EDC) contamination in Indian food found that while all tested foods—especially dairy and meat—contained organochlorine pesticides, PCBs, PBDEs, and dioxins, overall dietary exposure levels were comparable to or lower than those in Europe despite weaker regulations in India. Urban Delhi markets had higher contamination than peri-urban areas, with organochlorine pesticides being the primary contaminants, yet Indians’ lower meat consumption meant their total EDC exposure was similar to Europeans’ despite some European foods having higher chemical residues. The findings highlight that EDC contamination is a global food system issue driven by international trade of food and animal feed, underscoring the need for internationally harmonized standards on EDC limits in food to protect public health worldwide, as chemical exposures that increase risks for diseases like breast cancer cross borders through the global food supply.

No results found.

You have Successfully Subscribed!

Share This